Multicenter, randomized, placebo‐controlled, double‐blind clinical trial of escitalopram on the progression‐delaying effects in Alzheimer's disease
Objectives A series of preclinical studies have suggested that selective serotonin reuptake
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …
Multicenter, randomized, placebo‐controlled, double‐blind clinical trial of escitalopram on the progression‐delaying effects in Alzheimer's disease
YM Choe, KW Kim, JH Jhoo, SH Ryu, EH Seo… - International Journal of …, 2016 - infona.pl
Objectives A series of preclinical studies have suggested that selective serotonin reuptake
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …
Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease
YM Choe, KW Kim, JH Jhoo, SH Ryu, EH Seo… - 2016 - pubmed.ncbi.nlm.nih.gov
Objectives A series of preclinical studies have suggested that selective serotonin reuptake
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …
Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease
YM Choe, KW Kim, JH Jhoo, SH Ryu… - … Journal of Geriatric …, 2016 - snucm.elsevierpure.com
Objectives: A series of preclinical studies have suggested that selective serotonin reuptake
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …
Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease
YM Choe, KW Kim, JH Jhoo, SH Ryu… - INTERNATIONAL …, 2016 - repository.hanyang.ac.kr
ObjectivesA series of preclinical studies have suggested that selective serotonin reuptake
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …
[PDF][PDF] Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease
YM Choe, KW Kim, JH Jhoo, SH Ryu, EH Seo… - 2015 - dementia.snu.ac.kr
Objectives: A series of preclinical studies have suggested that selective serotonin reuptake
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …
Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease
YM Choe, KW Kim, JH Jhoo, SH Ryu… - INTERNATIONAL …, 2016 - scholarworks.bwise.kr
ObjectivesA series of preclinical studies have suggested that selective serotonin reuptake
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …
Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease.
YM Choe, KW Kim, JH Jhoo, SH Ryu… - … Journal of Geriatric …, 2015 - europepmc.org
Objectives A series of preclinical studies have suggested that selective serotonin reuptake
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …
inhibitor antidepressants not only stimulate neurogenesis but also have neuroprotective …